title: VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism.
abstract: Recruitment and retention of circulating progenitor cells at the site of injured or ischemic tissues facilitates adult neo-vascularization. We hypothesized that cell therapy could modulate local neo-vascularization through the vascular endothelial growth factor (VEGF)/stromal cell-derived factor-1 (SDF-1) axis and by paracrine effects on local endothelial cells. We isolated from rat bone marrow a subset of multipotent adult progenitor cell-derived progenitor cells (MDPC). In vitro, MDPCs secreted multiple cytokines related to inflammation and angiogenesis, including monocyte chemotactic protein-1, SDF-1, basic fibroblast growth factor, and VEGF, and expressed the chemokine receptors CXCR4 and VEGFR1. To investigate in vivo properties, we transplanted MDPCs into the ischemic hind limbs of rats. Elevated levels of the chemokine SDF-1 and colocalization of CD11b(+) cells marked the initial phase of tissue remodeling after cell transplantation. Prolonged engraftment was observed in the adventitial-medial border region of arterioles of ischemic muscles. However, engrafted cells did not differentiate into endothelial or smooth muscle cells. Limb perfusion normalized 4 weeks after cell injection. Inhibition of SDF-1 reduced the engraftment of transplanted cells and decreased endothelial cell proliferation. These findings suggest a two-stage model whereby transplanted MDPCs modulate wound repair through recruitment of inflammatory cells to ischemic tissue. This is an important potential mechanism for cell transplantation, in addition to the direct modulation of local vascular cells through paracrine mechanisms.
authors.affiliation: Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Building 10-CRC, Bethesda, MD 20817, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Wragg
authors.forename: Jason A
authors.initials: JA
authors.lastname: Mellad
authors.forename: Leilani E
authors.initials: LE
authors.lastname: Beltran
authors.forename: Mikhail
authors.initials: M
authors.lastname: Konoplyannikov
authors.forename: Hong
authors.initials: H
authors.lastname: San
authors.forename: Sherry
authors.initials: S
authors.lastname: Boozer
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Deans
authors.forename: Anthony
authors.initials: A
authors.lastname: Mathur
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Lederman
authors.forename: Jason C
authors.initials: JC
authors.lastname: Kovacic
authors.forename: Manfred
authors.initials: M
authors.lastname: Boehm
mesh_terms: D053687:Adult Stem Cells / Q000473:pathology / Q000502:physiology* / Q000637:transplantation; D000818:Animals; D001854:Bone Marrow Cells / Q000473:pathology / Q000502:physiology; D039481:CD11b Antigen / Q000378:metabolism; D002454:Cell Differentiation; D019070:Cell Lineage; D049109:Cell Proliferation; D002478:Cells, Cultured; D054377:Chemokine CXCL12 / Q000037:antagonists & inhibitors / Q000502:physiology*; D005260:Female; D006614:Hindlimb; D007249:Inflammation / Q000276:immunology / Q000473:pathology / Q000628:therapy; D007511:Ischemia / Q000276:immunology / Q000473:pathology / Q000628:therapy; D055806:Microvessels / Q000503:physiopathology; D039902:Multipotent Stem Cells / Q000473:pathology / Q000502:physiology* / Q000637:transplantation; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000276:immunology; D018919:Neovascularization, Physiologic; D019899:Paracrine Communication; D051381:Rats; D011916:Rats, Inbred F344; D019718:Receptors, CXCR4 / Q000378:metabolism*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000378:metabolism*
chemical_list: D039481:CD11b Antigen; D054377:Chemokine CXCL12; C486264:Cxcr4 protein, rat; D019718:Receptors, CXCR4; D040281:Vascular Endothelial Growth Factor Receptor-1